Evermay Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $41.4K | Hold |
93
| – | – | 0.01% | 335 |
|
|
2025
Q1 | $45.1K | Hold |
93
| – | – | 0.01% | 331 |
|
|
2024
Q4 | $37.5K | Hold |
93
| – | – | 0.01% | 339 |
|
|
2024
Q3 | $43.3K | Sell |
93
-213
| -70% | -$99.1K | 0.01% | 349 |
|
|
2024
Q2 | $143K | Hold |
306
| – | – | 0.02% | 223 |
|
|
2024
Q1 | $128K | Sell |
306
-2
| -0.6% | -$836 | 0.02% | 249 |
|
|
2023
Q4 | $125K | Buy |
308
+2
| +0.7% | +$814 | 0.02% | 222 |
|
|
2023
Q3 | $106K | Hold |
306
| – | – | 0.02% | 232 |
|
|
2023
Q2 | $108K | Hold |
306
| – | – | 0.02% | 232 |
|
|
2023
Q1 | $96.4K | Buy |
306
+56
| +22% | +$17.6K | 0.02% | 242 |
|
|
2022
Q4 | $72.2K | Buy |
+250
| New | +$72.2K | 0.01% | 259 |
|